JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2003; 41:961-965, doi:10.1016/S0735-1097(02)03014-0
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v48,p1918)
Right arrow Correction
Right arrow Correction
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gum, P. A.
Right arrow Articles by Topol, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gum, P. A.
Right arrow Articles by Topol, E. J.

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

Patricia A. Gum, MD*, Kandice Kottke-Marchant, MD, PhD*, Patricia A. Welsh*, Jennifer White, MS* and Eric J. Topol, MD, FACC*,*

* Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA



View larger version (14K):

[in a new window]
  		Figure 1 Time-to-event curves, log rank chi-square = 5.05, p = 0.03. CVA = cerebrovascular accident; MI = myocardial infarction.

 


View larger version (8K):

[in a new window]
  		Figure 2 Events (death, myocardial infarction, or cerebrovascular accident) by mean percent platelet aggregation with adenosine diphosphate (ADP).

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.